REG - CAP-XX Limited - Ioxus intellectual property judgement

CAP XXAnnouncement

07/08/2020 15:20

RNS Number : 5477V
  
CAP-XX Limited
  
07 August 2020
  
 

 
 
7 August 2020
 
 
CAP-XX Limited
("CAP-XX" or the "Company")
 
Ioxus intellectual property judgement
 
CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, announces that the Delaware District Court has made a judgment in favour of CAP-XX against Ioxus, Inc ("Ioxus").  
The Court found that Ioxus is liable for infringing the patents-in-suit and awarded CAP-XX compensatory damages of $1,237,717 and enhanced damages of $3,713,152 and also awarded CAP-XX its attorney's fees. 
CAP-XX intends to vigorously pursue the recovery of these awards, though it is unclear at this time whether this will be successful.  
For further information contact:
 
CAP-XX Limited
Anthony Kongats (Chief Executive Officer)                               +61 (0) 2 9428 0139
 
Kreab (Financial PR)
Robert Speed                                                                            +44 (0) 20 7074 1800
 
Allenby Capital (Nominated Adviser and Broker)
David Hart / Alex Brearley                                                         +44 (0) 20 3328 5656
 
 
More information is available at www.cap-xx.com
 
Notes to Editors:
 
CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
MSCUBASRRSUWRAR